Charles River Laboratories’ virtual control group (VCG) database will be used in a toxicology study run by French biopharma ...
AbbVie has added another angle to its relationship with Nxera, with the Big Pharma paying $100 million upfront for a phase ...
Ultragenyx is laying off 20% of its workforce and axing drug development programs to cut its annual R&D budget to half of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results